Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Jiang Y, Guo L, Han L, Li H, Li C, Wen L, Song Y, Wang Z, Wang P, Guo Q, Zhao W, Liu M, Chen J, Wu Z, Yan Y, Xu K, Gu T, Wu X, He K, Su K, Han Y.
Jiang Y, et al.
J Cancer Res Clin Oncol. 2023 Nov;149(15):14271-14282. doi: 10.1007/s00432-023-05089-z. Epub 2023 Aug 10.
J Cancer Res Clin Oncol. 2023.
PMID: 37561208